세포 분류 마그네틱 비드에 관한 시장 조사 보고서

시장개요

Cell sorting magnetic beads are critical tools in biomedical research and cell therapy, with rapid market growth in recent years. The global magnetic beads market reached USD 3.89 10억 2024 and is projected to exceed USD 16.01 10억 단위로 2037, growing at a compound annual growth rate (CAGR) ~의 11.5%. Cell sorting beads account for 10–15% of the total cost in CAR-T cell therapy production. 하지만, over 95% of the market is dominated by international players like Miltenyi Biotec and Thermo Fisher, while Chinese domestic companies remain in the technological catch-up phase.  

주요 애플리케이션

CAR-T Cell Therapy: Used for high-purity T-cell isolation, achieving over 99% CD3cell purity post-sorting (예를 들어, CD3cell ratio reduced from 36.5% 에게 0.7% in clinical cases).

Immunology Research: Sorting immune cells (B cells, NK cells) via antigen-specific magnetic labeling.

Stem Cell Therapy: Isolation of hematopoietic stem cells and mesenchymal stem cells for regenerative medicine.

In Vitro Diagnostics(IVD): Rapid enrichment of circulating tumor cells (CTCs) or pathogens. 시장 동인  

Growth of Cell Therapy: Expanding CAR-T therapy commercialization drives demand, with magnetic beads constituting 10–15% of production costs.

Precision Medicine: High-purity cell isolation is essential for single-cell sequencing and personalized therapies.

Localization Trends: Chinese companies like GenScript offer GMP-grade CytoSinct™ beads at 20–30% lower prices than imports, supported by policies promoting domestic alternatives. Technology Advancements: Nano-sized beads (50–70 nm) with high antibody conjugation efficiency and superparamagnetic properties are mainstream.

Competitive Landscape

International Leaders: Miltenyi Biotec, 써모 피셔, and BD control over 90% of the high-end market with end-to-end solutions.

Domestic Players: Companies like GenScript and Beaver Biosciences focus on cost-effective mid-to-low-end markets. GenScript’s beads are used in CAR-T clinical trials.

Technical Challenges: Key barriers include bead size uniformity, antibody conjugation efficiency, and batch consistency. Domestic firms face hurdles in scaling nano-bead production.

미래 전망

The cell sorting magnetic beads market is expected to grow at over 12% CAGR from 2025 에게 2030, driven by cell and gene therapy expansion. Chinese companies may achieve over 30% import substitution in 3–5 years, particularly in GMP-grade bead production, supported by policies like the 14th Five-Year Plan for biopharma innovation.  

공급자

상하이 링쥔 생명공학 유한회사, 주식회사에 설립되었습니다 2016 생체자성재료 및 핵산추출시약 전문제조업체입니다..

핵산 추출 및 정제 분야에서 풍부한 경험을 보유하고 있습니다., 단백질 정제, 세포 분리, 화학발광, 및 기타 기술 분야.

우리의 제품은 많은 분야에서 널리 사용됩니다., 의료 테스트와 같은, 유전자 검사, 대학 연구, 유전자 육종, 등. 우리는 제품을 제공할 뿐만 아니라 OEM도 수행할 수 있습니다., ODM, 그리고 다른 필요. 관련된 필요사항이 있는 경우, 저희에게 연락하게 자유롭게 느끼십시오 .